EICHORCondition: Complex Coronary Lesions · Sponsor: ECRI bv
The IVUS CHIP trial is a post-marketing strategy study in which patients with complex coronary lesions, undergoing percutaneous coronary intervention (PCI), are treated either with intravascular ultrasound (IVUS) guided PCI or angiographic guided PCI . The IVUS-guided PCI approach is indicated to reduce the frequency of target-lesion failure (cardiac death, target-vessel myocardial infarction, and clinically indicated target-lesion revascularization) in patients with complex coronary lesions undergoing PCI. The objective of this study is to assess the superiority of an IVUS-guided approach versus an angio-guided approach in patients with complex coronary lesions undergoing PCI.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| OLVZ | Aalst, Belgium | — |
| CHU | Charleroi, Belgium | — |
| ZOL Sint-Jan | Genk, Belgium | — |
| University Hospital Gasthuisberg | Leuven, Belgium | — |
| Clinique Saint-Augustin | Bordeaux, France | — |
| Cardiovascular Institute of Grenoble, GHM | Grenoble, France | — |
| Hopital Privé Jacques Cartier | Massy, France | — |
| Centre Cardiologique du Nord Saint-Denis | Saint-Denis, France | — |
| CHU | Toulouse, France | — |
| Clinique Pasteur | Toulouse, France | — |
| CHRU Tours - HopitalTrousseau | Tours, France | — |
| Segeberger Kliniken | Bad Segeberg, Germany | — |
+ 25 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04854070